ALDH6A1 and cancer: Based on the pan-cancer analysis, both ABAT and ALDH6A1 were significantly down-expressed in three types of renal cell carcinomas, KIRC, kidney renal papillary cell carcinoma (KIRP), and kidney chromophobe (KICH) (Fig. 3g–h).